Source: Breathe, 16 (2) 200113; 10.1183/20734735.0113-2020
Disease area: Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
Oleg Epelbaum, Irene Galperin. In defence of extrapolation but not improvisation in SARS-CoV-2 lung disease. Breathe, 16 (2) 200113; 10.1183/20734735.0113-2020

Member's Comments

No comment yet.

Related content which might interest you: The environment, epigenetics and lung disease Source: Annual Congress 2013 –PG6 Epigenetics of asthma and COPD Year: 2013 Host–microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease Source: Eur Respir J, 56 (2) 1902320; 10.1183/13993003.02320-2019 Year: 2020 Determinants of lung cancer evolution: immune escape and inflammation Source: International Congress 2018 – Scientific Year in Review Year: 2018 Personalising airway clearance in chronic lung disease Source: Eur Respir Rev 2017; 26: 160086 Year: 2017 Local immune protection mechanisms during bacterial infection of the airways in patients with interstitial lung diseases Source: Annual Congress 2009 - Mechanisms of infection: what's new? Year: 2009 The adaptive immune system, autoimmunity and COPD: lessons from human studies Source: Annual Congress 2007 - T- and B-cells in COPD: a role for adaptive immunity in the pathogenesis of COPD? Year: 2007 Immunology and defence mechanism of the developing lung Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=60 Year: 2006 The estimation of adaptation of functional systems of the patients with a lung cancer and secondary inflammatory changes Source: Eur Respir J 2006; 28: Suppl. 50, 751s Year: 2006 The integrated stress response in lung disease Source: International Congress 2015 – Dysfunctional protein quality control in paediatric and adult lung diseases Year: 2015 The time-controlled adaptive ventilation protocol: mechanistic approach to reducing ventilator-induced lung injury Source: Eur Respir Rev, 28 (152) 180126; 10.1183/16000617.0126-2018 Year: 2019 The adaptive immune system, autoimmunity and COPD: lessons from animal models Source: Annual Congress 2007 - T- and B-cells in COPD: a role for adaptive immunity in the pathogenesis of COPD? Year: 2007 From ineffective tumor immune response to immunomodulation in lung cancer Source: ERS Research Seminar 2017 – Immunotherapy: a new standard of care in thoracic malignancies? Year: 2017 Pulmonary defence mechanisms and inflammatory pathways in bronchiectasis Source: Eur Respir Mon 2011; 52: 11-21 Year: 2011 Siphonage lung disease Source: Virtual Congress 2020 – Respiratory critical care Year: 2020 Ageing of the immune system: a contribution to lung disease? Source: Annual Congress 2012 - Searching for the secrets of senescence in the lung Year: 2012 Control of lung defence by mucins and macrophages: ancient defence mechanisms with modern functions Source: Eur Respir J 2016; 48: 1201-1214 Year: 2016 Pivotal role of the HMGB1/sRAGE axis in drug-induced lung injury in advanced lung cancer with pre-existing interstitial lung disease Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Angiogenesis in lung development, injury and repair: implications for chronic lung disease of prematurity Source: Annual Congress 2008 - Physiological year in review Year: 2008